Skip to main content
Log in

Ketorolac following Mastectomy: Is There an Increased Risk of Reoperation?

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. McCormick PJ, Assel M, Van Zee KJ, et al. Intraoperative Ketorolac is associated with risk of reoperation after mastectomy: a single-center examination. Ann Surg Oncol. 2021/02/24 2021.

  2. Kelley BP, Chung KC, Chung T-T, et al. Postoperative Ketorolac in Breast and Body Contouring Procedures: A Nationwide Claims Analysis. Plast Reconstr Surg. 2018;142(4):472e-e480.

    Article  CAS  Google Scholar 

  3. Nordestgaard AT, Rasmussen LS, Sillesen M, et al. Smoking and risk of surgical bleeding: nationwide analysis of 5,452,411 surgical cases. Transfusion. 2020;60(8):1689–99.

    Article  Google Scholar 

  4. Lin SL, Gao PT, Ni WK, et al. Controlled hypertension under hemostasis prevents post-gastric endoscopic submucosal dissection bleeding: a prospective randomized controlled trial. Surg Endosc. Feb 4 2021.

  5. Walter ND, Rice PL, Redente EF, et al. Wound healing after trauma may predispose to lung cancer metastasis: review of potential mechanisms. Am J Respir Cell Molec Biol. 2011;44(5):591–6.

    Article  CAS  Google Scholar 

  6. Forget P, Machiels JP, Coulie PG, et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol. 2013;20(Suppl 3):S650–60.

    Article  Google Scholar 

  7. Forget P, Bentin C, Machiels JP, Berliere M, Coulie PG, De Kock M. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. Br J Anaesth. 2014;113(Suppl 1):i82–7.

    Article  CAS  Google Scholar 

  8. Liu Z, Cheng S, Fu G, Ji F, Wang C, Cao M. Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer. Life Sci. 2020;251:117604.

    Article  CAS  Google Scholar 

  9. Kelley BP, Chung KC, Chung TT, et al. Postoperative Ketorolac in breast and body contouring procedures: a nationwide claims analysis. Plast Reconstr Surg. 2018;142(4):472e-e480.

    Article  CAS  Google Scholar 

  10. Barkho JO, Li YK, Duku E, Thoma A. Ketorolac may increase hematoma risk in reduction mammaplasty: a case-control study. Plast Reconstr Surg Global Open. 2018;6(3):e1699.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xueyang Tang MD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, L., Zhao, X., Xiang, B. et al. Ketorolac following Mastectomy: Is There an Increased Risk of Reoperation?. Ann Surg Oncol 28 (Suppl 3), 775–776 (2021). https://doi.org/10.1245/s10434-021-10071-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10071-5

Navigation